Novak Djokovic bought a company developing a cure for coronavirus. Previously, he was not allowed into Australia due to lack of vaccinations.

Novak Djokovic bought An 80% stake in QuantBioRes, a Danish biotech company developing a coronavirus drug. She is working on a peptide that prevents infection of human cells. Representatives of QuantBioRes emphasized that they are engaged in the treatment of coronavirus, and not in the search for a vaccine against it.

Earlier, the tennis player was not allowed to the Australian Open, as the country’s authorities were not convinced of the reasons for the Serb’s medical withdrawal from vaccination.

On January 5, Djokovic arrived in Melbourne to compete in the Australian Open, but the Australian authorities denied him entry into the country. According to information source The Times, a member of his team made a gross mistake in applying for a visa, and the athlete was about to cross the border with a document that does not include information about the medical exemption from vaccination against coronavirus. On January 17, Djokovic was banned from entering Australia for three years.

Djokovic spoke out against compulsory vaccination against coronavirus, and also refused to say whether he had been vaccinated or not. However, the tennis player declared that he does not want to be “labeled as a supporter or opponent of vaccination.” In the summer of 2020, he held a tennis tournament in Serbia, despite the strict quarantine measures that were in place around the world. During it, he himself, as well as several athletes and members of delegations, became infected with the coronavirus.